SCHEMBL7971002

SCHEMBL7971002

Cc1ccc2c(c1)OC(C)C(=S)N2

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.39
CREBBP Q92793 2/20 0.39
PARP1 P09874 2/20 0.38
CHRM1 P11229 2/20 0.36
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
PGR P06401 4/20 0.33
NR3C1 P04150 2/20 0.33
AR P10275 2/20 0.33
MMP12 P39900 1/20 0.33
PSMB8 P28062 1/20 0.32
KEAP1 Q14145 1/20 0.32
TSHR P16473 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
CECR2 Q9BXF3 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988135 0.86 BRD4 (0.53) BRD4CREBBPPARP1MMP12TSHR
SCHEMBL7000943 0.81 PARP1 (0.37) BRD4CREBBPPARP1PDE3BPDE3A
SCHEMBL5672049 0.79 PARP1 (0.62) BRD4CREBBPPARP1PDE3BPDE3A
SCHEMBL7982291 0.79 PARP1 (0.33) BRD4CREBBPPARP1
SCHEMBL23552860 0.76 PARP1 (0.45) BRD4CREBBPPARP1PGR
SCHEMBL7003210 0.75 KMT2A (0.48) PARP1CHRM1PGRNR3C1AR
SCHEMBL7711230 0.71 PARP1 (0.37) BRD4CREBBPPARP1CHRM1PDE3B
SCHEMBL7001562 0.71 MAPK9 (0.33) PARP1TSHRNPSR1ALDH1A1GAA
SCHEMBL7984345 0.71 HSD17B10 (0.43) BRD4CREBBPPARP1CHRM1PDE3B
SCHEMBL7000474 0.71 PARP1 (0.37) BRD4CREBBPPARP1PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6191127-B1 ANTIINFLAMMATORY AGENTS, AUTOIMMUNE DISEASES, CARDIOVASCULAR DISORDERS, NERVOUS SYSTEM DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed